AU2002951868A0 - Compound i - Google Patents

Compound i

Info

Publication number
AU2002951868A0
AU2002951868A0 AU2002951868A AU2002951868A AU2002951868A0 AU 2002951868 A0 AU2002951868 A0 AU 2002951868A0 AU 2002951868 A AU2002951868 A AU 2002951868A AU 2002951868 A AU2002951868 A AU 2002951868A AU 2002951868 A0 AU2002951868 A0 AU 2002951868A0
Authority
AU
Australia
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002951868A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alterity Therapeutics Ltd
Original Assignee
Prana Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prana Biotechnology Ltd filed Critical Prana Biotechnology Ltd
Priority to AU2002951868A priority Critical patent/AU2002951868A0/en
Publication of AU2002951868A0 publication Critical patent/AU2002951868A0/en
Priority to DK03798831.8T priority patent/DK1558585T3/en
Priority to RU2005109392/04A priority patent/RU2005109392A/en
Priority to CN200380105290.6A priority patent/CN1720238B/en
Priority to AU2003265740A priority patent/AU2003265740B8/en
Priority to JP2004540379A priority patent/JP4690043B2/en
Priority to US10/530,137 priority patent/US7692011B2/en
Priority to EP03798831.8A priority patent/EP1558585B1/en
Priority to ES03798831.8T priority patent/ES2440217T3/en
Priority to BR0315008-9A priority patent/BR0315008A/en
Priority to PCT/AU2003/001303 priority patent/WO2004031161A1/en
Priority to CA2500952A priority patent/CA2500952C/en
Priority to NZ539211A priority patent/NZ539211A/en
Priority to EP10004952A priority patent/EP2210892A3/en
Priority to KR1020057005802A priority patent/KR101122782B1/en
Priority to MXPA05003607A priority patent/MXPA05003607A/en
Priority to IL167694A priority patent/IL167694A/en
Priority to HK05107510.1A priority patent/HK1074202A1/en
Priority to US12/717,631 priority patent/US20100160346A1/en
Priority to JP2010162383A priority patent/JP2010285437A/en
Abandoned legal-status Critical Current

Links

AU2002951868A 2002-10-04 2002-10-04 Compound i Abandoned AU2002951868A0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
AU2002951868A AU2002951868A0 (en) 2002-10-04 2002-10-04 Compound i
MXPA05003607A MXPA05003607A (en) 2002-10-04 2003-10-03 Neurologically-active compounds.
ES03798831.8T ES2440217T3 (en) 2002-10-04 2003-10-03 Neurologically active compounds
PCT/AU2003/001303 WO2004031161A1 (en) 2002-10-04 2003-10-03 Neurologically-active compounds
CN200380105290.6A CN1720238B (en) 2002-10-04 2003-10-03 Neurologically-active compounds
AU2003265740A AU2003265740B8 (en) 2002-10-04 2003-10-03 Neurologically-active compounds
JP2004540379A JP4690043B2 (en) 2002-10-04 2003-10-03 Nerve active compounds
US10/530,137 US7692011B2 (en) 2002-10-04 2003-10-03 8-hydroxy and 8-mercapto quinazolinones
EP03798831.8A EP1558585B1 (en) 2002-10-04 2003-10-03 Neurologically-active compounds
DK03798831.8T DK1558585T3 (en) 2002-10-04 2003-10-03 Neurologically active compounds
BR0315008-9A BR0315008A (en) 2002-10-04 2003-10-03 Neurologically Active Compounds
RU2005109392/04A RU2005109392A (en) 2002-10-04 2003-10-03 NEUROLOGICALLY ACTIVE COMPOUNDS
CA2500952A CA2500952C (en) 2002-10-04 2003-10-03 Neurologically-active compounds
NZ539211A NZ539211A (en) 2002-10-04 2003-10-03 Neurologically-active compounds
EP10004952A EP2210892A3 (en) 2002-10-04 2003-10-03 Neurologically-active compounds
KR1020057005802A KR101122782B1 (en) 2002-10-04 2003-10-03 Neurologically-active compounds
IL167694A IL167694A (en) 2002-10-04 2005-03-28 Use of substituted quinazolin-4-one derivatives for the preparation of medicaments and pharmaceutical compositions comprising the compounds
HK05107510.1A HK1074202A1 (en) 2002-10-04 2005-08-26 Neurologically-active compounds
US12/717,631 US20100160346A1 (en) 2002-10-04 2010-03-04 Neurologically active compounds
JP2010162383A JP2010285437A (en) 2002-10-04 2010-07-20 Neurologically-active compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002951868A AU2002951868A0 (en) 2002-10-04 2002-10-04 Compound i

Publications (1)

Publication Number Publication Date
AU2002951868A0 true AU2002951868A0 (en) 2002-10-24

Family

ID=28679501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002951868A Abandoned AU2002951868A0 (en) 2002-10-04 2002-10-04 Compound i

Country Status (2)

Country Link
CN (1) CN1720238B (en)
AU (1) AU2002951868A0 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0710737A2 (en) * 2006-04-14 2011-05-10 Prana Biotechnology Ltd use of compounds pb-10 33 useful for the treatment of age-related macular degeneration (amd) as well as said compounds
JP6784942B2 (en) * 2014-12-02 2020-11-18 オールテリティ セラピューティクス リミテッド 4H-pyrido [1,2-a] pyrimidine-4-one compound
CN106146410B (en) * 2015-04-03 2018-10-12 中南大学 6- amino -4 (3H)-Quinazol derivative and its preparation method and use
CN109897008B (en) * 2019-03-20 2022-05-03 中南大学 2-benzoyl-6-amino-4 (3H) -quinazolinone derivative and synthesis method and application thereof
CA3133671C (en) * 2019-06-03 2023-12-19 Aihol Corporation Hyaluronan conjugates and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385990A (en) * 1992-11-02 1995-01-31 Lord Corporation Structural adhesive composition having high temperature resistance
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues

Also Published As

Publication number Publication date
CN1720238B (en) 2011-08-03
CN1720238A (en) 2006-01-11

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2002335152A1 (en) Robot-phone
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2003279366A1 (en) Novel compounds
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003279495A1 (en) Alert-modeling
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003298156A1 (en) Biphenylcarboxamides
AUPS044102A0 (en) New compound
AU2002951868A0 (en) Compound i
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003251259A1 (en) Novel compounds
AU2002318053A1 (en) Suplier
AU2003255322A1 (en) Compounds
AU2002341221A1 (en) Honey-brandy
AU2003275480A1 (en) Compounds
AU2003226541A1 (en) Novel compounds
AU2002951863A0 (en) Compound v
AU2002951864A0 (en) Compound ii
AU2002951865A0 (en) Compound iii